101 related articles for article (PubMed ID: 3184468)
1. [Molecular biologic study in chronic myelogenous leukemia and its related disorders].
Ohyashiki JH; Ohyashiki K; Toyama K
Rinsho Ketsueki; 1988 Jul; 29(7):1010-7. PubMed ID: 3184468
[No Abstract] [Full Text] [Related]
2. [bcr rearrangement in variant Ph1-positive chronic myelocytic leukemia and unclassified myeloproliferative disorders].
Sekito N; Takahashi I
Rinsho Ketsueki; 1988 Jul; 29(7):1018-24. PubMed ID: 3184469
[No Abstract] [Full Text] [Related]
3. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
Farhi DC; Luckey CN; Siddiqui AM
Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
[TBL] [Abstract][Full Text] [Related]
4. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
5. [DNA analysis in chronic myelogenous leukemia, especially in clinical application of bcr gene rearrangement].
Funato T; Bando Y; Ichikawa K; Ohtani H; Tokuhiro H
Rinsho Byori; 1989 Mar; 37(3):306-10. PubMed ID: 2746921
[No Abstract] [Full Text] [Related]
6. Abnormal chromatin clumping in granulocytes in a case of Ph1-negative, BCR-ABL rearrangement positive, haematologically atypical chronic myeloid leukaemia (CML).
Tertian G; Misrahi M; Diallo D; Mielot F; Leonard C; Salmeron S; Tchernia G
Nouv Rev Fr Hematol (1978); 1995; 37(4):245-7. PubMed ID: 8904205
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia.
Haigh S; Cuthbert G
Cancer Genet Cytogenet; 2004 Dec; 155(2):132-7. PubMed ID: 15571798
[TBL] [Abstract][Full Text] [Related]
8. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
[TBL] [Abstract][Full Text] [Related]
9. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
Fugazza G; Garuti A; Marchelli S; Miglino M; Bruzzone R; Gatti AM; Castello S; Sessarego M
Cancer Genet Cytogenet; 2005 Dec; 163(2):173-5. PubMed ID: 16337863
[TBL] [Abstract][Full Text] [Related]
10. [Molecular biology studies in chronic myeloid leukemia].
Cervantes F
Med Clin (Barc); 1993 Oct; 101(14):538-40. PubMed ID: 8231399
[No Abstract] [Full Text] [Related]
11. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in biological and therapeutic aspects of myeloproliferative disorders.
Mancini M; Diverio D; Alimena G; Mandelli F
Curr Opin Hematol; 1994 Jul; 1(4):261-7. PubMed ID: 9371292
[TBL] [Abstract][Full Text] [Related]
13. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
[TBL] [Abstract][Full Text] [Related]
14. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
Xue YQ
Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
[TBL] [Abstract][Full Text] [Related]
15. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
Bock O
Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608
[TBL] [Abstract][Full Text] [Related]
16. [Loss of junB expression causes a myeloproliferative syndrome resembling chronic myeloid leukemia].
Jochum W; Passegue E; Wagner EF
Verh Dtsch Ges Pathol; 1999; 83():216-7. PubMed ID: 10714213
[TBL] [Abstract][Full Text] [Related]
17. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
[TBL] [Abstract][Full Text] [Related]
18. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.
Nakata Y
Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600
[TBL] [Abstract][Full Text] [Related]
19. [Chronic myeloid leukemia. Diagnosis, development and prognosis].
Tanzer J
Rev Prat; 1988 Jun; 38(18):1210-6. PubMed ID: 3175491
[No Abstract] [Full Text] [Related]
20. Ph-positive and -negative myeloproliferative syndromes may co-exist.
Mauro MJ; Loriaux M; Deininger MW
Leukemia; 2004 Jul; 18(7):1305-7. PubMed ID: 15103389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
